FDA approves Tabrecta for metastatic lung cancer Dr. Kamal Kant Kohli7 May 2020 3:26 AM ISTThe U.S. Food and Drug Administration has approved Tabrecta (capmatinib) for the treatment of adult patients with metastatic non-small cell lung...
Oncocyte, CORE Diagnostics join hands for expansion of DetermaRx in India Ruchika Sharma24 April 2020 11:00 AM ISTDetermaRxâ„¢ is Oncocyte's treatment stratification test that identifies patients at high risk for lung cancer recurrence, who may benefit from adjuvant...
COPD linked to increased risk of lung cancer in nonsmokers Dr. Kamal Kant Kohli3 April 2020 5:45 AM ISTChronic Obstructive Pulmonary Disease is tied to heightened risk of lung cancer in people who have never smoked and risk is similar to that of smokers...
Smoking cessation heals damaged cells, cuts lung cancer risk Medha Baranwal2 Feb 2020 7:30 PM ISTUK: Quitting smoking could do much more than just stopping further damage to the lungs, a recent study has suggested. According to the study,...
Supportive care in lung cancer patients receiving concurrent chemotherapy and radiotherapy: ESTRO and ESMO Guideline Hina Zahid17 Jan 2020 5:36 PM ISTConcurrent chemotherapy and radiotherapy (CCRT) followed by durvalumab immune therapy in appropriate patients is considered to be the standard of care...
Dalmia Healthcare organises event for spreading awareness about air pollution Medical Dialogues Bureau25 Jan 2019 12:33 PM ISTDalmia Healthcare, housed under the Dalmia Group, recently organised an event, providing a platform to the doctors and healers to spread awareness...
Wb: Doctor Licence cancelled for Overlooking Abnormal X-ray, Radiology Opinion Garima27 April 2018 4:45 PM ISTKolkata: Holding "guilty of infamous conduct in a professional respect", the West Bengal Medical Council (WBMC) has ordered the removal of a doctor's...
AstraZeneca wins FDA breakthrough status for durvalumab savita thakur thakur18 Feb 2016 9:16 AM ISTLONDON: The U.S. Food and Drug Administration has granted breakthrough therapy designation to AstraZeneca's biggest new drug hope durvalumab as a...
Major advances seen in 'non-small cell lung cancer' treatment Meghna A Singhania3 Jan 2016 4:15 PM ISTWashington: Although the most common type of lung cancer - non-small cell lung cancer (NSCLC) - has recently seen major treatment advances in some...
Triple therapy to help fight deadly lung cancer savita thakur thakur2 Jan 2016 11:08 AM ISTWashington: In experimental models of lung cancer, researchers have found that a combination of two drugs plus radiation can help treat resistant lung...
Europe recommends lung cancer drugs from AstraZeneca, Lilly savita thakur thakur19 Dec 2015 11:41 AM ISTThe European Medicines Agency said  its experts had recommended marketing approval for lung cancer drugs developed by AstraZeneca and Eli Lilly and...
Cancer on the rise in lower income countries : Study savita thakur thakur15 Dec 2015 12:46 PM ISTWASHINGTON: Many low-and middle-income countries have seen cancer rates rise, partially due to increases in risk factors that are typical of Western...
